parameters. When interpreting data on lymphocyte numbers in patients, lymphoIn various allergic and inflammatory lung diseases the number and subset com-cyte dynamics in the bronchoalveolar space have to be considered, and in the position of lymphocytes in the bronchoalveolar lavage (BAL) fluid are taken as future it may be possible to manipulate these lymphocyte fluxes for therapeutic indicators of the state of the disease. The number of lymphocytes in the BAL fluid purposes. (Thorax 1997;52:1078-1080 depends on three main parameters: (1) entry into the bronchoalveolar space from Keywords: bronchoalveolar lavage, lymphocytes, origin, the different compartments of the lung, (2) proliferation, apoptosis, lymphocyte dynamics. persistence in the bronchoalveolar space which is modified by the rate of local proBronchoalveolar lavage (BAL) has become a liferation and apoptosis, and (3) exit into routine clinical procedure applied with inthe draining bronchial lymph node via the creasing frequency. Due to a minimum of side lymphatic system. In healthy individuals effects it can even be applied in volunteers, in lymphocytes in the BAL fluid seem to be patients with allergies such as asthma, and a stable pool: each day there is hardly any during intensive care. Recommendations for a entry, local cell division or cell death and and chemokines which may regulate these control subjects.
matory, toxic and allergic reactions all
and diffuse panbronchiolitis, after allergen pro- and chemokines which may regulate these control subjects. [2] [3] [4] One basic prerequisite for a meaningful interpretation of data on lymphocytes in BAL fluid is that not only the percentage of lymphocytes or their subsets but also the total number per volume are documented in all studies. In most situations only a single lavage can be performed in an individual patient. Thus, the data are like a photographic snapshot -only indicative of pathophysiological events if it portrays a stable condition rather than one stage of a disease process. As lymphocytes continuously patrol through nearly all organs of the body, leaving the blood to traverse the organ parenchyma and returning to the blood via the lymphatic system, the number of lymphocytes in the lung also depends on the rate of entry of lymphocytes into the bronchoalveolar space, the rate of exit, and the fate of the lymphocytes within the bronchoalveolar space (fig 1) . partments of the lung:
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5 the intravascular group.bmj.com on October 11, 2017 -Published by http://thorax.bmj.com/ Downloaded from "marginal pool", the interstitial pool, within the gration to the draining lymph node.
11 From an immunological point of view it is relevant that bronchial epithelium and the bronchial lamina propria. There is no hard evidence in ex-lymphocytes from the bronchoalveolar space return to the lymphoid system where individual perimental animals or in humans that lymphocytes migrate from all these compartments clones can expand and the lymphocytes can migrate to other organs. No regulatory factors into the bronchoalveolar space. Less than 10% of the lymphocytes in the BAL fluid are B are known so far which influence the migration of lymphocytes from the BAL fluid to the lymph cells, and among the T cells the CD4+ cells outnumber the CD8+ cells. There are many nodes but adhesion molecules might play a role. The adhesion molecules which are known more so-called "memory" (>85%) than "naive" T lymphocytes in the BAL fluid, which as regulatory molecules in lymphocyte migration via high endothelial venules in lymph is different from the composition of lymphocytes in other lung compartments. 5 Either nodes -for example, selectins, integrins and molecules of the super Ig family -are obviously this subset preferentially migrates into the bronchoalveolar space or "naive" lymphocytes not important in the adhesion of lymphocytes to pulmonary endothelium. change their phenotype on arrival.
Very little is known of the origin of lymphocytes in the BAL fluid and the route from the blood to the bronchoalveolar space (fig 1) .   Proliferation of lymphocytes can be measured Thoracic duct lymphocytes were labelled in vitro with FITC in rats and injected intraby the uptake of DNA precursors -for example, 3 H-thymidine ( 3 H-TdR), bromodeoxy uridine venously. A labelling index of >1% was found in all lymphoid organs studied and remained (BrdU), or markers for lymphocytes in the cell cycle such as Ki67. In patients with HIV in the blood for several days. However, in the bronchoalveolar space no FITC+ lymphocytes infection, lymphocytes obtained by BAL incorporated more 3 H-TdR than those from were found. 5 When pigs were immunised orally with a lung pathogenic bacterium they were healthy volunteers and proliferation was confined to the CD8+ population. 6 Chilosi et al 7 protected in a subsequent challenge and the numbers of CD4+ and CD8+ lymphocytes studied the expression of Ki67 on T lymphocytes recovered from BAL fluid and found increased in parallel in the bronchoalveolar space. The bronchoalveolar space is therefore no Ki67-labelled T lymphocytes in specimens from healthy volunteers but in patients with included in the integrated mucosal system. In allergic reactions provoked by local antiactive sarcoidosis approximately 6% of all T cells were labelled.
gens instillation induced an increased number of lymphocytes in the bronchoalveolar space. As recently summarised, 4 different gases (such as SO 2 , NO 2 , and ozone) as well as lipo- Programmed cell death, also called apoptosis, polysaccharide instillation 12 in the airways of healthy volunteers all resulted in increased can be identified by the expression of CD95 (Fas). In a recent study Agostini et al 8 reported numbers of lymphocytes in the BAL fluid. The rapidity of the effect (within a few hours) makes that Fas antigen was weakly expressed in BAL fluid samples from control subjects but was it likely that these increases are due to enhanced entry into the bronchoalveolar space because upregulated in BAL fluid from patients with sarcoidosis. Studies on the termination of pul-enhanced local proliferation would hardly be so quick, and exit is also very low under normal monary immune reactions -for example, using sheep red blood cells as an antigen in mice -circumstances. It is not known whether the toxic gases themselves attract the lymphocytes revealed the role of apoptosis in the elimination of lung lymphocytes. 9 In a recent study the from the different compartments. Local effects of interleukins and chemokines during immune marker bcl-2, which inhibits apoptosis resulting in prolonged cell survival, was found to occur reactions could also be candidates for opening the door for lymphocytes to enter the bronchomore frequently in lymphocytic interstitial pneumonia.
10 For the lymphocytes of healthy alveolar space. 4 individuals neither local proliferation nor apoptosis seem to play a role in the bronchoalveolar space. In lung diseases, however, these two Therapeutic potential and conclusions It should always be kept in mind that increased parameters indicate an increased lymphocyte turnover.
numbers of lymphocytes in BAL fluid could be caused by increased influx, increased local proliferation, reduced apoptosis or decreased efflux, or even a combination of all of these      One long standing hypothesis was that lym-parameters. Minor differences in the influx of lymphocytes could cause major increases in phocytes from the bronchoalveolar space are transported by the mucociliary escalator into lymphocyte numbers over time resulting in an accumulation in the bronchoalveolar space. the trachea, then coughed up, swallowed, and destroyed. In healthy young pigs labelled lym-When more data are available on the role of adhesion molecules, cytokines, and chemophocytes obtained from the peripheral blood were instilled into the bronchoalveolar space. kines as factors influencing lymphocytes in their speed of entry, persistence in the bronchoAfter a few hours they were seen in the draining bronchial lymph node. Lymphocyte subsets alveolar space, and rate of exit from the bronchoalveolar space, new therapeutic differed in their speed and frequency of mi- 
